Am J Dermatopathol 37(10):801802
Clin Pharmacol Ther 1987
Multiple CVB variants have been shown to induce cell degeneration, pyknosis, reduction of islet identity genes, and decreased insulin content and secretion in primary human islets cultured in vitro or transplanted into diabetic NOD mice (141, 143)
These effects typically occur during dose initiation or escalation and often diminish over time as the body adjusts to the medication
Retrieved from Farokhnia, M., McDiarmid, G
(Buhler) [5] Sources and Research References [1] Arla Foods Ingredients targets GLP-1 companion nutrition at Vitafoods Europe, 2026 [2] MyNetDiary Launches GLP-1 Companion for Ozempic, Wegovy, and Mounjaro Users, 2026 [3] HTBA to launch Leanara GLP-1 companion ingredient at Vitafoods Europe 2026, 2026 [4] Amazon launches GLP-1 weight loss program, promising fast, convenient access, 2026 [5] Brightseed Launches BioMetaControl, a Nature-Inspired GLP-1 Companion for Metabolic Health., 2025 GLP-1 Companion Products Market Definition The GLP-1 companion products market is made up of a variety of complementary products and services aimed at improving the efficacy, safety, and overall success of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro